Ftse Mib
36.719,35
0,00%
DAX
21.510,84
0,00%
S&P 500
6.037,88
0,72%
NASDAQ
19.654,02
1,35%
Bitcoin
97.886,65
0,03%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Europa EU PHAXIAM Therapeutics SA (PHXM) PHAXIAM Therapeutics SA (PHXM) Notizie

PHAXIAM Therapeutics SA

PHXM
1,82
0,00 (0,00%)
05 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: Euronext
Tipo: Azione Ordinaria
Valuta: EUR

Ultime notizie

Data Ora Fonte Titolo
31/1/202507:00BWPHAXIAM Provides An Update On The Deployment Of Its Strategy..
30/1/202518:38BWPHAXIAM Therapeutics et Technophage entament une..
13/1/202518:00BWPHAXIAM Therapeutics Announces Its Financial Calendar for..
07/1/202518:00BWPHAXIAM Therapeutics annonce des données cliniques..
06/1/202518:00BWPHAXIAM: Monthly Information Related to Total Number of..
30/12/202417:45BWPHAXIAM Therapeutics présente les données cliniques de..
05/12/202418:00UKREGPHAXIAM Therapeutics : monthly information related to total..
05/12/202418:00UKREGPHAXIAM Therapeutics : information mensuelle relative au..
27/11/202414:30UKREGPHAXIAM présente une stratégie de développement ambitieuse..
27/11/202414:30UKREGPHAXIAM Therapeutics presents an ambitious development..
18/11/202418:00UKREGPHAXIAM a présenté son test IVD Phagogramme et..
18/11/202418:00GLOBEPHAXIAM Presented its IVD Phagogram test and updated phage..
18/11/202418:00UKREGPHAXIAM Presented its IVD Phagogram test and updated phage..
13/11/202417:45UKREGPHAXIAM Reports Third-Quarter 2024 Financial Information
13/11/202417:45UKREGPHAXIAM publie l’information financière du troisième..
08/11/202418:00UKREGMonthly information related to total number of voting rights..
08/11/202418:00UKREGInformation mensuelle relative au nombre total de droits de..
04/11/202418:00UKREGPHAXIAM Therapeutics Receives FDA Clearance to Initiate..
04/11/202418:00UKREGPHAXIAM Therapeutics obtient l’autorisation de la FDA..
10/10/202418:00UKREGMonthly information related to total number of voting rights..
10/10/202418:00UKREGInformation mensuelle relative au nombre total de droits de..
09/10/202418:00UKREGPHAXIAM Therapeutics announces the validation of a new..
09/10/202418:00UKREGPHAXIAM Therapeutics annonce la validation d’une nouvelle..
25/9/202417:45UKREGPHAXIAM fait le point sur ses activités et publie ses..
25/9/202417:45UKREGPHAXIAM Provides Business and Financial Update For the First..
25/9/202417:45UKREGPHAXIAM : RAPPORT FINANCIER SEMESTRIEL
03/7/202418:00GLOBEMonthly information related to total number of voting rights..
28/6/202417:45GLOBEResults of the Combined General Meeting of 28 June 2024
27/6/202417:45GLOBEPHAXIAM Therapeutics annonce le succès de son augmentation..
12/6/202408:00GLOBELancement d'une augmentation de capital avec maintien du DPS..
07/6/202417:45GLOBEPHAXIAM announces the availability of the preparatory..
05/6/202418:00GLOBEMonthly information related to total number of voting rights..
15/5/202417:45GLOBEPHAXIAM Therapeutics fait le point sur ses activités et..
03/5/202418:05GLOBEMonthly information related to total number of voting rights..
15/4/202407:30GLOBEPHAXIAM Therapeutics annonce le recrutement du premier..
09/4/202418:00GLOBEMonthly information related to total number of voting rights..
05/4/202418:00GLOBEPHAXIAM Therapeutics annonce le dépôt de son Document..
20/3/202418:00UKREGPHAXIAM Therapeutics publie ses résultats annuels 2023 et..
20/3/202418:00UKREGPHAXIAM Announces 2023 Full-Year Results and Provides..
11/3/202407:00GLOBEPHAXIAM Therapeutics announces effectiveness of voluntary..
05/3/202418:00GLOBEMonthly information related to total number of voting rights..
20/2/202422:05GLOBEPHAXIAM Therapeutics annonce son intention de procéder au..
06/2/202422:05GLOBEInformation mensuelle relative au nombre total de droits de..
Apertura: Min: Max:
Chiusura: 1,82

La tua Cronologia

EU
PHXM
PHAXIAM Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci